| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/14/2025 | $58.00 | Mkt Outperform | Citizens JMP |
| 6/16/2025 | Outperform | William Blair | |
| 6/16/2025 | $48.00 | Buy | Truist |
| 6/16/2025 | $48.00 | Buy | Stifel |
| 6/16/2025 | $45.00 | Outperform | Raymond James |
| 6/16/2025 | $41.00 | Overweight | Piper Sandler |
| 6/16/2025 | $46.00 | Overweight | Morgan Stanley |
| 6/16/2025 | $47.00 | Buy | Needham |
| 6/16/2025 | $45.00 | Overweight | KeyBanc Capital Markets |
| 6/16/2025 | $50.00 | Outperform | Evercore ISI |
SCHEDULE 13G - Hinge Health, Inc. (0001673743) (Subject)
SCHEDULE 13G - Hinge Health, Inc. (0001673743) (Subject)
SCHEDULE 13G - Hinge Health, Inc. (0001673743) (Subject)
SCHEDULE 13G - Hinge Health, Inc. (0001673743) (Subject)
SCHEDULE 13G - Hinge Health, Inc. (0001673743) (Subject)
8-K - Hinge Health, Inc. (0001673743) (Filer)
SCHEDULE 13G - Hinge Health, Inc. (0001673743) (Subject)
10-Q - Hinge Health, Inc. (0001673743) (Filer)
8-K - Hinge Health, Inc. (0001673743) (Filer)
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Citizens JMP initiated coverage of Hinge Health with a rating of Mkt Outperform and set a new price target of $58.00
William Blair initiated coverage of Hinge Health with a rating of Outperform
Truist initiated coverage of Hinge Health with a rating of Buy and set a new price target of $48.00
Stifel initiated coverage of Hinge Health with a rating of Buy and set a new price target of $48.00
Raymond James initiated coverage of Hinge Health with a rating of Outperform and set a new price target of $45.00
Piper Sandler initiated coverage of Hinge Health with a rating of Overweight and set a new price target of $41.00
Morgan Stanley initiated coverage of Hinge Health with a rating of Overweight and set a new price target of $46.00
Needham initiated coverage of Hinge Health with a rating of Buy and set a new price target of $47.00
KeyBanc Capital Markets initiated coverage of Hinge Health with a rating of Overweight and set a new price target of $45.00
Evercore ISI initiated coverage of Hinge Health with a rating of Outperform and set a new price target of $50.00
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - Hinge Health, Inc. (0001673743) (Issuer)
Fastest customizable press release news feed in the world
Hinge Health, Inc. (NYSE:HNGE) today announced financial results for the second quarter ended June 30, 2025. "In Q2 we delivered year-over-year revenue growth of 55% and a strong free cash flow margin, underlining the market's embrace of our AI-powered platform," said Daniel Perez, Co-Founder and CEO, Hinge Health. "The journey of automating healthcare delivery will be challenging, but we're excited about our momentum and are moving with haste to capture this opportunity." Second Quarter 2025 Financial Highlights: Revenue increased 55% year-over-year to $139.1 million compared to revenue of $89.8 million in Q2 2024. GAAP gross margin was 70% compared to 74% in Q2 2024. Non-GAAP gr
Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarterly period ended June 30, 2025, after the close of the market on Tuesday, August 5, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting w
Combined with Hinge Health's AI-powered exercise therapy program, HingeSelect adds access to high-quality in-person providers for members at up to 50% below PPO rates Hinge Health, Inc. (NYSE:HNGE), today announced the launch of HingeSelect, a high-performance provider network for musculoskeletal (MSK) care. Hinge Health's technology and in-house orthopedic physicians triage and direct downstream care, prioritizing the most appropriate evidence-based treatment. When in-person care, such as imaging or injections is required, members are seamlessly connected to pre-vetted providers at up to 50% below PPO rates. Combined with Hinge Health's AI-powered digital exercise therapy, HingeSelect pr
Methodology validated by leading global benefits consultant Hinge Health, Inc. (NYSE:HNGE) today announced results from a medical claims analysis revealing an average $2,343 savings per member per year on care for chronic musculoskeletal (MSK) conditions and a 2.4x return on investment (ROI) for fully insured health plan members using its digital MSK platform. The methodology of the medical claims analysis of 4,788 health plan members was validated by Gallagher, a leading global insurance brokerage, risk management, and consulting firm. MSK costs remain one of the top drivers of health costs, placing increasing pressure on benefits leaders to ensure programs deliver value and cost-effic
Live finance-specific insights
Hinge Health, Inc. (NYSE:HNGE) today announced financial results for the second quarter ended June 30, 2025. "In Q2 we delivered year-over-year revenue growth of 55% and a strong free cash flow margin, underlining the market's embrace of our AI-powered platform," said Daniel Perez, Co-Founder and CEO, Hinge Health. "The journey of automating healthcare delivery will be challenging, but we're excited about our momentum and are moving with haste to capture this opportunity." Second Quarter 2025 Financial Highlights: Revenue increased 55% year-over-year to $139.1 million compared to revenue of $89.8 million in Q2 2024. GAAP gross margin was 70% compared to 74% in Q2 2024. Non-GAAP gr
Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarterly period ended June 30, 2025, after the close of the market on Tuesday, August 5, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting w